Amicus Therapeutics, Inc. (FOLD)
NASDAQ·Healthcare·Biotechnology
$14.49
+0.28%
Mkt Cap $4.55B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 20, 2026 | $180.53M | $185.21M | +2.60% | $0.07 | $0.01 | -86.00% | — | — |
| Q4 2025 Nov 4, 2025 | $185.00M | $169.06M | -8.62% | $0.12 | $0.17 | +41.67% | — | — |
| Q3 2025 Jul 31, 2025 | $165.26M | $154.69M | -6.40% | $0.02 | $0.01 | -50.00% | — | — |
| Q2 2025 May 1, 2025 | $147.49M | $125.25M | -15.08% | $0.08 | $0.03 | -62.50% | — | — |
| Q1 2025 Feb 19, 2025 | $147.87M | $149.71M | +1.24% | $0.02 | $0.09 | +350.00% | — | — |
| Q4 2024 Nov 6, 2024 | $147.37M | $141.52M | -3.97% | $0.08 | $0.10 | +25.00% | — | — |
| Q3 2024 Aug 8, 2024 | $121.24M | $126.67M | +4.48% | $0.05 | $0.06 | +9.83% | — | — |
| Q2 2024 May 9, 2024 | $111.19M | $110.40M | -0.71% | -$0.06 | -$0.02 | +66.67% | — | — |
| Q1 2024 Feb 28, 2024 | $114.33M | $115.08M | +0.66% | -$0.06 | -$0.11 | -83.33% | — | — |
| Q4 2023 Nov 8, 2023 | $113.39M | $103.50M | -8.72% | -$0.08 | -$0.07 | +12.50% | — | — |
| Q3 2023 Aug 8, 2023 | $89.87M | $94.50M | +5.16% | -$0.12 | -$0.15 | -25.00% | — | — |
| Q2 2023 May 10, 2023 | $83.08M | $86.27M | +3.84% | -$0.13 | -$0.18 | -38.46% | — | — |
| Q1 2023 Mar 1, 2023 | $86.31M | $88.10M | +2.07% | -$0.13 | -$0.19 | -46.15% | — | — |
| Q4 2022 Nov 7, 2022 | $84.21M | $81.69M | -2.99% | -$0.19 | -$0.12 | +36.84% | — | — |
| Q3 2022 Aug 4, 2022 | $85.87M | $80.73M | -5.98% | -$0.23 | -$0.21 | +8.70% | — | — |
| Q2 2022 May 9, 2022 | $77.18M | $78.72M | +1.98% | -$0.24 | -$0.30 | -25.00% | — | — |
| Q1 2022 Feb 24, 2022 | $83.41M | $82.15M | -1.50% | -$0.14 | -$0.29 | -107.14% | — | — |
| Q4 2021 Nov 9, 2021 | $80.11M | $79.55M | -0.71% | -$0.18 | -$0.19 | -5.56% | — | — |
| Q3 2021 Aug 5, 2021 | $77.41M | $77.41M | +0.00% | -$0.21 | -$0.19 | +9.52% | — | — |
| Q2 2021 May 10, 2021 | $71.85M | $66.40M | -7.58% | -$0.23 | -$0.25 | -8.70% | — | — |